<?xml version="1.0" encoding="UTF-8"?>
<p>Recent research has focused on the eCBS as a possible alternative target to treat PTSD [
 <xref rid="B27-life-11-00214" ref-type="bibr">27</xref>,
 <xref rid="B28-life-11-00214" ref-type="bibr">28</xref>]. Evidence highlighted a reduction of endocannabinoid levels [
 <xref rid="B29-life-11-00214" ref-type="bibr">29</xref>] and cannabinoid receptor type 1 (CB1) receptors up-regulation in the brain of PTSD patients [
 <xref rid="B30-life-11-00214" ref-type="bibr">30</xref>]. Thus, the use of components derived from 
 <italic>Cannabis sativa</italic> as cannabidiol (CBD) and Δ
 <sup>9</sup>-tetrahydrocannabinol (Δ
 <sup>9</sup>-THC) has drawn increasing interest as a possible alternative approach to treat PTSD. To reinforce this assumption several studies support cannabis use as self-medication to cope with PTSD symptoms [
 <xref rid="B4-life-11-00214" ref-type="bibr">4</xref>,
 <xref rid="B31-life-11-00214" ref-type="bibr">31</xref>]. 
</p>
